Phase 1/2 study of preoperative docetaxel and mitoxantrone for high‐risk prostate cancer

Abstract

: Preoperative chemotherapy with docetaxel and mitoxantrone is feasible. Approximately half of the high-risk patients remain free of disease recurrence at 5 years, and clinical and molecular predictors of early recurrence were identified. Cancer 2010. (c) 2010 American Cancer Society.